Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Molecules ; 28(23)2023 Dec 03.
Artículo en Inglés | MEDLINE | ID: mdl-38067642

RESUMEN

(1) Background: almond peels are rich in polyphenols such as catechin and epicatechin, which are important anti-free-radical agents, anti-inflammatory compounds, and capable of breaking down cholesterol plaques. This work aims to evaluate the biological and technological activity of a "green" dry aqueous extract from Sicilian almond peels, a waste product of the food industry, and to develop healthy nutraceuticals with natural ingredients. Eudraguard® Natural is a natural coating polymer chosen to develop atomized formulations that improve the technological properties of the extract. (2) Methods: the antioxidant and free radical scavenger activity of the extract was rated using different methods (DPPH assay, ABTS, ORAC, NO). The metalloproteinases of the extracts (MMP-2 and MMP-9), the enhanced inhibition of the final glycation products, and the effects of the compounds on cell viability were also tested. All pure materials and formulations were characterized using UV, HPLC, FTIR, DSC, and SEM methods. (3) Results: almond peel extract showed appreciable antioxidant and free radical activity with a stronger NO inhibition effect, strong activity on MMP-2, and good antiglycative effects. In light of this, a food supplement with added health value was formulated. Eudraguard® Natural acted as a swelling substrate by improving extract solubility and dissolution/release (4) Conclusions: almond peel extract has significant antioxidant activity and MMP/AGE inhibition effects, resulting in an optimal candidate to formulate safe microsystems with potential antimetabolic activity. Eudraguard® Natural is capable of obtaining spray-dried microsystems with an improvement in the extract's biological and technological characteristics. It also protects the dry extract from degradation and oxidation, prolonging the shelf life of the final product.


Asunto(s)
Antioxidantes , Prunus dulcis , Antioxidantes/farmacología , Antioxidantes/química , Metaloproteinasa 2 de la Matriz , Extractos Vegetales/farmacología , Extractos Vegetales/química , Suplementos Dietéticos , Radicales Libres/química
2.
Future Med Chem ; 11(11): 1245-1258, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-30974972

RESUMEN

Aim: Despite the serious side effects, analgesics acting on opioid receptors are still considered the best way to get antinociception. Matrix metalloproteinases, a large family of zinc-dependent proteases implicated in many pathological conditions, such as diabetes and osteoarthritis, are also involved in inflammation and pain. Methodology & results: Looking for evidence of possible interactions of opioid pathways and inflammation mediators, molecular modeling studies of a series of recently developed µ-opioid receptor benzomorphanic agonists together with biological data on pain and inflammation molecular targets, allowed us to hypothesize a possible correlation between µ-opioid receptor system and MMP-9. Conclusion: A new compound, (-)-MML1017, emerged as a possible dual-acting agent able to interact selectively and potently with the two molecular targets.


Asunto(s)
Analgésicos/farmacología , Benzomorfanos/farmacología , Metaloproteinasa 9 de la Matriz/metabolismo , Inhibidores de la Metaloproteinasa de la Matriz/farmacología , Receptores Opioides mu/agonistas , Analgésicos/química , Benzomorfanos/química , Descubrimiento de Drogas , Células HEK293 , Humanos , Metaloproteinasa 9 de la Matriz/química , Inhibidores de la Metaloproteinasa de la Matriz/química , Modelos Moleculares
3.
Nat Prod Res ; 33(6): 843-850, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29232982

RESUMEN

The aim of this study was the evaluation of antibacterial and antioxidant properties of Monofloral Etna Castanea sativa Miller honeys. Escherichia coli ATCC 25,922, Pseudomonas aeruginosa ATCC 27,853, Enterococcus faecalis ATCC 29,211 and Staphylococcus aureus ATCC 29,213 were investigated for their susceptibilities to two different honeys. Antioxidant activity was evaluated by ORAC, NO scavenger assays, FRAP and DPPH. Antioxidant activity and antibacterial properties were compared with chestnut honeys from different geographical areas and with Manuka honey. UPLC-MS/MS was used for major components characteri sation.


Asunto(s)
Antibacterianos/farmacología , Antioxidantes/farmacología , Fagaceae/química , Miel/análisis , Antibacterianos/aislamiento & purificación , Antioxidantes/aislamiento & purificación , Cromatografía Liquida , Enterococcus faecalis/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Flavonoides/aislamiento & purificación , Flavonoides/farmacología , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Fenoles/aislamiento & purificación , Fenoles/farmacología , Fitoquímicos/aislamiento & purificación , Fitoquímicos/farmacología , Pseudomonas aeruginosa/efectos de los fármacos , Sicilia , Staphylococcus aureus/efectos de los fármacos , Espectrometría de Masas en Tándem
4.
Planta Med ; 85(3): 258-265, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30206907

RESUMEN

Crocin and crocetin are two interesting constituents of saffron (Crocus sativus) that possess important biological activities. Their use as therapeutic agents is strongly compromised by a scarce stability, poor absorption, and low bioavailability. Therefore, to improve these unfavorable features, the aim of the present work has been to apply a nanotechnological approach based on the formulation of solid lipid nanoparticles containing crocin and crocetin. Solid lipid nanoparticles were formulated according to crocin and crocetin chemical properties, using a variation of the quasi-emulsion solvent diffusion method to formulate crocin-solid lipid nanoparticles, while crocetin-solid lipid nanoparticles were prepared following the solvent diffusion method. Morphology and dimensional distribution of solid lipid nanoparticles have been characterized by differential scanning calorimetry and photon correlation spectroscopy, respectively, while the effect of drug incorporation versus time has been studied by Turbiscan technology. In order to verify the role of the nanotechnological approach on the biological activities of crocin and crocetin, the antioxidant and antiproliferative effects of these carotenoids once incorporated in lipid nanoparticles have been evaluated. For this aim, the oxygen radical absorbance capacity assay and the MTT test were used, respectively.The results pointed out the formulation of nanometric dispersions endowed with high homogeneity and stability, with an encapsulation efficiency ranging from 80 (crocetin-solid lipid nanoparticles) to 94% (crocin-crocetin). The oxygen radical absorbance capacity assay evidenced an interesting and prolonged antioxidant activity of crocin and crocetin once encapsulated in solid lipid nanoparticles, while the nanoencapsulation strategy showed a different mechanism in ameliorating the cytotoxic effect of these two substances.


Asunto(s)
Antioxidantes/administración & dosificación , Carotenoides/administración & dosificación , Citotoxinas/administración & dosificación , Antineoplásicos/administración & dosificación , Antineoplásicos/farmacocinética , Antioxidantes/farmacocinética , Disponibilidad Biológica , Carotenoides/farmacocinética , Línea Celular Tumoral , Citotoxinas/farmacocinética , Sistemas de Liberación de Medicamentos , Humanos , Nanopartículas , Vitamina A/análogos & derivados
5.
Molecules ; 23(2)2018 Feb 14.
Artículo en Inglés | MEDLINE | ID: mdl-29443898

RESUMEN

Nine 2-(1,2-benzothiazol-3-yl)-N-(4-oxo-2-phenyl-1,3-thiazolidin-3-yl)propanamides combining a benzisothiazole and 4-thiazolidinone in one framework were designed and synthesized. The aim of the study was to verify their effectiveness to affect the inflammatory/oxidative process in which free oxygen and nitrite (ROS and RNS) radicals, inflammatory mediators, such as nuclear factor κB (NF-κB), and matrix metalloproteinases (MMPs) are involved. Docking studies of all the compounds were performed in order to explore their binding mode at the MMP-9 protein. An appreciable anti-inflammatory/potential wound healing effects of the tested compounds was highlighted. Derivative 23, bearing a 4-carboxyphenyl substituent at C2 of the 4-thiazolidinone ring, exhibited the highest activity, being able to inhibit MMP-9 at nanomolar level(IC50 = 40 nM).


Asunto(s)
Inflamación/tratamiento farmacológico , Inhibidores de la Metaloproteinasa de la Matriz/química , Tiazolidinas/química , Humanos , Inflamación/metabolismo , Metaloproteinasa 9 de la Matriz/química , Metaloproteinasa 9 de la Matriz/efectos de los fármacos , Inhibidores de la Metaloproteinasa de la Matriz/síntesis química , Simulación del Acoplamiento Molecular , FN-kappa B/metabolismo , Propano/síntesis química , Propano/química , Tiazolidinas/síntesis química
6.
Crit Rev Food Sci Nutr ; 58(6): 893-904, 2018 Apr 13.
Artículo en Inglés | MEDLINE | ID: mdl-27646710

RESUMEN

The diet polyphenols are a secondary metabolites of plants able to act on inflammation process. Their anti-inflammatory activity is articulated through several mechanisms that are related to their antioxidative and radical scavengers properties. Our work is focused on a novel approach to inflammatory disease management, based on anti-glycative and matrix metalloproteinases (MMPs) inhibition effects, as a connected phenomena. To better understand these correlation, polyphenols Structure-Activity Relationship (SAR) studies were also reported. The antioxidant polyphenols inhibit the AGEs at different levels of the glycation process in the following ways: (1) prevention of Amadori adduct oxidation; (2) trapping reactive dycarbonyl compounds; (3) attenuation of receptor for AGEs (RAGE) expression. Moreover, several flavonoids with radical scavenging property showed also MMPs inhibition interact directly with MMPs or indirectly via radical scavengers and AGEs reduction. The essential polyphenols features involved in these mechanisms are C2-C3 double bond and number and position of hydroxyl, glycosyl and O-methyl groups. These factors induce a change in molecular planarity interfering with the hydrogen bond formation, electron delocalization and metal ion chelation. In particular, C2-C3 double bond improve the antioxidant and MMPs inhibition, while the hydroxylation, glycosylation and methylation induce a positive and negative correlation, respectively.


Asunto(s)
Antioxidantes/farmacología , Productos Finales de Glicación Avanzada/metabolismo , Inflamación/tratamiento farmacológico , Metaloproteasas/metabolismo , Polifenoles/farmacología , Flavonoides/farmacología , Productos Finales de Glicación Avanzada/antagonistas & inhibidores , Glicosilación , Humanos , Inhibidores de la Metaloproteinasa de la Matriz/farmacología , Metaloproteasas/antagonistas & inhibidores , Relación Estructura-Actividad
7.
Drug Res (Stuttg) ; 68(3): 132-138, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29108086

RESUMEN

BACKGROUND: Inflammation is a dynamic process that occur on vascularized tissue in response to different stimuli causing cell injury and tissue degeneration. Reactive oxygen and nitrogen species (ROS and RNS) and advanced glycation end products (AGEs) have a key mediatory role in the development and progression of degenerative tissue process. The bioflavonoids possess a broad-spectrum of pharmacological activities. Their capability is related to their chemical structure. METHODS: In this study we evaluated and compare antioxidant, anti-glycative and anti-degenerative actions of two flavones apigenin and luteolin and a flavonol quercetin, in function of their hydroxyl groups arrangement. Moreover we assay, on NCTC 2544 and chondrocytes cultures, the flavonoids capacity to modulate NO and glycosamminoglycans levels, index of antidegenerative capacity. RESULTS: All tested flavonoids act as free radicals scavengers (ROO• and NO•) and advanced glycation end products inhibitors, in agreement with their BDE, IP and molecular planarity. Quercetin showed a high ORAC value (2.70±0.12 ORAC Units), according to a low BDE (74.54 Kcal/mol) and IP (174.44 Kcal/mol) values. Luteolin is the most active compound in the NO (48.19±0.18%) and AGEs (60.06±0.52%) inhibition, in function of a low torsion angle (16.3°) between the 3-OH moiety and C'6 carbon atom. CONCLUSION: All tested flavonoids posses a protective role on degenerative tissue events. They acts in different manner depending on the functional groups, the biological substrate and the concentration used. In any case, it can be considered a suitable product preventing a degenerative processes.


Asunto(s)
Apigenina/farmacología , Condrocitos/efectos de los fármacos , Queratinocitos/efectos de los fármacos , Luteolina/farmacología , Quercetina/farmacología , Antiinflamatorios/farmacología , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Glicosaminoglicanos/metabolismo , Humanos , Óxido Nítrico/metabolismo , Relación Estructura-Actividad
8.
Oxid Med Cell Longev ; 2017: 2867630, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29230268

RESUMEN

Alginate and ß-cyclodextrin were used to produce easily dosable and spray-dried microsystems of a dried blood orange extract with antidysmetabolic properties, obtained from a by-product fluid extract. The spray-dried applied conditions were able to obtain a concentrate dried extract without the loss of AOA and with TPC and TMA values of 35-40% higher than that of the starting material. They were also effective in producing microparticles with 80-100% of encapsulation efficiency. The 2% sodium alginate was capable of improving the extract shelf life, while the beta-cyclodextrin (1 : 1 molar ratio with dried extract) prolonged the extract antioxidant efficiency by 6 hours. The good inhibition effect of the dried extract on the AGE formation and the MMP-2 and MMP-9 activity is presumably due to a synergic effect exerted by both anthocyanin and bioflavonoid extract compounds and was improved by the use of alginate and cyclodextrin.


Asunto(s)
Alginatos/metabolismo , Antioxidantes/uso terapéutico , Citrus sinensis/química , Inhibidores de la Metaloproteinasa de la Matriz/uso terapéutico , Extractos Vegetales/química , Polifenoles/metabolismo , Antioxidantes/farmacología , Ácido Glucurónico/metabolismo , Ácidos Hexurónicos/metabolismo , Inhibidores de la Metaloproteinasa de la Matriz/farmacología
9.
Molecules ; 22(6)2017 May 27.
Artículo en Inglés | MEDLINE | ID: mdl-28555014

RESUMEN

Idebenone (IDE) has been proposed for the treatment of neurodegenerative diseases involving mitochondria dysfunctions. Unfortunately, to date, IDE therapeutic treatments have not been as successful as expected. To improve IDE efficacy, in this work we describe a two-step approach: (1) synthesis of IDE ester derivatives by covalent linking IDE to other two antioxidants, trolox (IDETRL) and lipoic acid (IDELIP), to obtain a synergic effect; (2) loading of IDE, IDETRL, or IDELIP into solid lipid nanoparticles (SLN) to improve IDE and its esters' water solubility while increasing and prolonging their antioxidant activity. IDE and its derivatives loaded SLN showed good physico-chemical and technological properties (spherical shape, mean particle sizes 23-25 nm, single peak in the size distribution, ζ potential values -1.76/-2.89 mV, and good stability at room temperature). In vitro antioxidant activity of these SLN was evaluated in comparison with free drugs by means of oxygen radical absorbance capacity (ORAC) test. IDETRL and IDELIP showed a greater antioxidant activity than IDE and encapsulation of IDE and its derivatives into SLN was able to prolong their antioxidant activity. These results suggest that loading IDETRL and IDELIP into SLN could be a useful strategy to improve IDE efficacy.


Asunto(s)
Antioxidantes/química , Lípidos/química , Nanopartículas/química , Ubiquinona/análogos & derivados , Tamaño de la Partícula , Ácido Tióctico/química , Ubiquinona/química
10.
Oxid Med Cell Longev ; 2017: 7503240, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28367273

RESUMEN

The aim of this study was to evaluate the antidegenerative effect in osteoarthritis damage of eriocitrin alone and eriocitrin formulated as innovative "dietary flavonoid supplement." A complexation between eriocitrin and hydroxypropyl ß-cyclodextrin by solubilization/freeze-drying method was performed. The complex in solution was evaluated by phase solubility studies and the optimal 1 : 2 flavanone/cyclodextrin molar ratio was selected. Hydroxypropyl ß-cyclodextrin was able to complex eriocitrin as confirmed by UV-Vis absorption, DSC, and FTIR studies. The complex formed increased the eriocitrin water solubility (from 4.1 ± 0.2 g·L-1 to 11.0 ± 0.1 g·L-1) and dissolution rate (from 37.0% to 100%) in 30 min. The in vitro studies exhibit the notion that eriocitrin and its complex inhibit AGEs in a similar manner because hydroxypropyl ß-cyclodextrin does not interfere with the flavanone intrinsic property. Instead, the presence of cyclodextrin improves eriocitrin antioxidant stability maintaining a high fluorescence value until 8 hours with respect to the pure materials. Moreover, hydroxypropyl ß-cyclodextrin showed moderate GAGs restoration acting synergistically with the complexed compound to maintain the structural chondrocytes integrity. The results point out that ERT/HP-betaCD complex possesses technological and biological characteristics able to obtain an easily soluble nutraceutical product, which reduces the degenerative and oxidative damage which occurs in osteoarthritis, and improve the patient compliance.


Asunto(s)
Suplementos Dietéticos , Flavonoides/farmacología , Estrés Oxidativo/efectos de los fármacos , 2-Hidroxipropil-beta-Ciclodextrina , Adulto , Rastreo Diferencial de Calorimetría , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Condrocitos/citología , Condrocitos/metabolismo , Composición de Medicamentos , Flavanonas/química , Flavanonas/farmacología , Flavanonas/uso terapéutico , Flavonoides/química , Flavonoides/uso terapéutico , Humanos , Osteoartritis/metabolismo , Osteoartritis/patología , Osteoartritis/prevención & control , Solubilidad , Espectrofotometría Ultravioleta , Espectroscopía Infrarroja por Transformada de Fourier , beta-Ciclodextrinas/química
11.
Planta Med ; 83(11): 901-911, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28288492

RESUMEN

Metalloproteases are a family of zinc-containing endopeptidases involved in a variety of pathological disorders. The use of flavonoid derivatives as potential metalloprotease inhibitors has recently increased.Particular plants growing in Sicily are an excellent yielder of the flavonoids luteolin, apigenin, and their respective glycoside derivatives (7-O-rutinoside, 7-O-glucoside, and 7-O-glucuronide).The inhibitory activity of luteolin, apigenin, and their respective glycoside derivatives on the metalloproteases MMP-1, MMP-3, MMP-13, MMP-8, and MMP-9 was assessed and rationalized correlating in vitro target-oriented screening and in silico docking.The flavones apigenin, luteolin, and their respective glucosides have good ability to interact with metalloproteases and can also be lead compounds for further development. Glycones are more active on MMP-1, -3, -8, and -13 than MMP-9. Collagenases MMP-1, MMP-8, and MMP-13 are inhibited by compounds having rutinoside glycones. Apigenin and luteolin are inactive on MMP-1, -3, and -8, which can be interpreted as a better selectivity for both -9 and -13 peptidases. The more active compounds are apigenin-7-O-rutinoside on MMP-1 and luteolin-7-O-rutinoside on MMP-3. The lowest IC50 values were also found for apigenin-7-O-glucuronide, apigenin-7-O-rutinoside, and luteolin-7-O-glucuronide. The glycoside moiety might allow for a better anchoring to the active site of MMP-1, -3, -8, -9, and -13. Overall, the in silico data are substantially in agreement with the in vitro ones (fluorimetric assay).


Asunto(s)
Flavonoides/farmacología , Inhibidores de la Metaloproteinasa de la Matriz/farmacología , Apigenina/química , Apigenina/farmacología , Sistemas de Liberación de Medicamentos , Luteolina/química , Luteolina/farmacología , Inhibidores de la Metaloproteinasa de la Matriz/química , Inhibidores de la Metaloproteinasa de la Matriz/aislamiento & purificación , Metaloproteinasas de la Matriz , Simulación del Acoplamiento Molecular
12.
Planta Med ; 83(5): 398-404, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-27124246

RESUMEN

Sesamol is a natural phenolic compound extracted from Sesamum indicum seed oil. Sesamol is endowed with several beneficial effects, but its use as a topical agent is strongly compromised by unfavorable chemical-physical properties. Therefore, to improve its characteristics, the aim of the present work was the formulation of nanostructured lipid carriers as drug delivery systems for topical administration of sesamol.Two different nanostructured lipid carrier systems have been produced based on the same solid lipid (Compritol® 888 ATO) but in a mixture with two different kinds of oil phase such as Miglyol® 812 (nanostructured lipid carrier-M) and sesame oil (nanostructured lipid carrier-PLUS). Morphology and dimensional distribution of nanostructured lipid carriers have been characterized by differential scanning calorimetry and photon correlation spectroscopy, respectively. The release pattern of sesamol from nanostructured lipid carriers was evaluated in vitro determining drug percutaneous absorption through excised human skin. Furthermore, an oxygen radical absorbance capacity assay was used to determine their antioxidant activity.From the results obtained, the method used to formulate nanostructured lipid carriers led to a homogeneous dispersion of particles in a nanometric range. Sesamol has been encapsulated efficiently in both nanostructured lipid carriers, with higher encapsulation efficiency values (> 90 %) when sesame oil was used as the oil phase (nanostructured lipid carrier-PLUS). In vitro evidences show that nanostructured lipid carrier dispersions were able to control the rate of sesamol diffusion through the skin, with respect to the reference formulations.Furthermore, the oxygen radical absorbance capacity assay pointed out an interesting and prolonged antioxidant activity of sesamol, especially when vehiculated by nanostructured lipid carrier-PLUS.


Asunto(s)
Antioxidantes/administración & dosificación , Benzodioxoles/administración & dosificación , Nanoestructuras , Vehículos Farmacéuticos , Fenoles/administración & dosificación , Administración Tópica , Adulto , Antioxidantes/farmacología , Benzodioxoles/química , Benzodioxoles/farmacología , Humanos , Técnicas In Vitro , Lípidos , Estructura Molecular , Tamaño de la Partícula , Fenoles/química , Fenoles/farmacología , Absorción Cutánea
13.
Mater Sci Eng C Mater Biol Appl ; 71: 669-677, 2017 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-27987758

RESUMEN

Crocin, a potent antioxidant obtained from saffron, shows anticancer activity in in vivo models. Unfortunately unfavorable physicochemical features compromise its use in topical therapy. The present study describes the preparation and characterization of nanostructured lipid dispersions as drug delivery systems for topical administration of crocin and the evaluation of antioxidant and antiproliferative effects of crocin once encapsulated into nanostructured lipid dispersions. Nanostructured lipid dispersions based on monoolein in mixture with sodium cholate and sodium caseinate have been characterized by cryo-TEM and PCS. Crocin permeation was evaluated in vitro by Franz cells, while the oxygen radical absorbance capacity assay was used to evaluate the antioxidant activity. Furthermore, the antiproliferative activity was tested in vitro by the MTT test using a human melanoma cell line. The emulsification of monoolein with sodium cholate and sodium caseinate led to dispersions of cubosomes, hexasomes, sponge systems and vesicles, depending on the employed emulsifiers. Permeation and shelf life studies demonstrated that nanostructured lipid dispersions enabled to control both rate of crocin diffusion through the skin and crocin degradation. The oxygen radical absorbance capacity assay pointed out an interesting and prolonged antioxidant activity of crocin while the MTT test showed an increase of crocin cytotoxic effect after incorporation in nanostructured lipid dispersions. This work has highlighted that nanostructured lipid dispersions can protect the labile molecule crocin from degradation, control its skin diffusion and prolong antioxidant activity, therefore suggesting the suitability of nanostructured lipid dispersions for crocin topical administration.


Asunto(s)
Antioxidantes , Carotenoides , Crocus/química , Sistemas de Liberación de Medicamentos/métodos , Melanoma/tratamiento farmacológico , Administración Tópica , Antioxidantes/química , Antioxidantes/farmacología , Carotenoides/química , Carotenoides/farmacología , Caseínas/química , Caseínas/farmacología , Línea Celular Tumoral , Emulsiones , Glicéridos/química , Glicéridos/farmacología , Humanos , Melanoma/metabolismo , Melanoma/patología , Colato de Sodio/química , Colato de Sodio/farmacología
14.
Int J Food Sci Nutr ; 66(8): 881-6, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26398677

RESUMEN

The aim of the present study is to compare three cultivars of prickly pear fruits ("Sanguigna" red, "Sulfarina" yellow and "Muscaredda" white) regarding the quality parameters of antioxidant activity, phenolic compounds, betalains and ascorbic acid (vitamin C). Depending on the crop operation, these cultivars are represented by "Agostane" and "Bastardoni" and are located at an altitude between 150 and 750 m, above sea level. Their antioxidant activity was evaluated by ORAC assay. Total phenolic compounds, betalains and ascorbic acid recovered from pulp juice, were determined by a spectrophotometric analysis. The results indicate that the different cultivars of prickly pear possess antioxidant activity in function of the type of the adopted practice. These fruits were derived from the practice of scozzolatura, by dropping the berries to encourage a second bloom of the plant. Among the "Bastardoni", the "Sulfarina" possesses the highest antioxidant activity.


Asunto(s)
Antioxidantes/química , Frutas/química , Opuntia/química , Fitoquímicos/química , Ácido Ascórbico/análisis , Betalaínas/análisis , Ácidos Picolínicos/análisis , Pigmentos Biológicos/análisis , Extractos Vegetales/análisis , Polifenoles/análisis , Espectrofotometría
15.
Bioorg Med Chem ; 23(7): 1551-6, 2015 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-25725607

RESUMEN

We report the synthesis, the antioxidant and the inhibitory activity (IC50) on metalloproteinases (MMPs) 3 and 13 of 2-benzo[d]isothiazolylimino-5-benzylidene-4-thiazolidinones. Their potential as protective agents in osteoarthritis (OA) was evaluated by biological assays on chondrocytes cultures, stimulated by IL-1ß. The chondroprotective capability, related both to antioxidant activity and to inhibition of MMPs, was studied in vitro, by determining nitric oxide production and glycosaminoglycans release. Moreover, selected derivatives 1h and 1g was studied for nuclear factor kappaB (NF-κB) inhibition by Western Blot analysis and for MMP-3 protein release using ELISA test. The structure-activity relationship of tested compounds demonstrates a favorable effect of the para substitution on the 5-benzilydene ring. Compound 1g shows a potent and selective activity on MMP-3 versus MMP-13. Accordingly, 1g possesses high antioxidant effect, NO lowering and GAGs restoring capability and also reduces the production of MMPs and NF-κB expression. Thus 1g can be considered as new potential chondroprotective agents.


Asunto(s)
Cartílago/efectos de los fármacos , Condrocitos/efectos de los fármacos , Tiazolidinas/química , Cartílago/enzimología , Cartílago/patología , Células Cultivadas , Condrocitos/enzimología , Condrocitos/patología , Humanos , Metaloproteinasa 13 de la Matriz/metabolismo , Metaloproteinasa 3 de la Matriz/metabolismo , Osteoartritis/enzimología , Osteoartritis/patología , Osteoartritis/prevención & control , Sustancias Protectoras/química , Sustancias Protectoras/farmacología , Sustancias Protectoras/uso terapéutico , Tiazolidinas/farmacología , Tiazolidinas/uso terapéutico
16.
Pharm Dev Technol ; 20(6): 716-23, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-24799075

RESUMEN

Idebenone (IDE) is a lipophilic benzoquinone electron carrier synthetic analogue of coenzyme Q10, which behaves as an antioxidant and free radical scavenging molecule. Recently, the therapeutic application of IDE in Leber's hereditary optic neuropathy has been discussed. This work was aimed at evaluating the encapsulation of IDE in solid-lipid nanoparticles (SLN). In particular, we tested the possibility of adapting the quasi-emulsion solvent diffusion technique, already proposed to produce polymeric nanoparticles, to prepare positively charged SLN with different compositions. Such a charge, due to the addition of a cationic lipid, would facilitate the interaction with the negatively charged eye surface epithelium, with a consequent longer pre-corneal residence time of the colloidal systems. In a preliminary evaluation of the produced IDE-loaded SLN, the antioxidant activity of the drug was demonstrated using an oxygen radical absorbance capacity assay. Encapsulation of the drug in the nanocarrier systems seems able to protect IDE from degradation and prolong its antioxidant potential.


Asunto(s)
Antioxidantes/administración & dosificación , Portadores de Fármacos/química , Lípidos/química , Nanopartículas/química , Ubiquinona/análogos & derivados , Antioxidantes/farmacología , Cationes/química , Especies Reactivas de Oxígeno/química , Ubiquinona/administración & dosificación , Ubiquinona/farmacología
17.
J Pharm Sci ; 102(7): 2349-61, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23686742

RESUMEN

Curcumin (CUR) is a well-known natural compound showing antioxidant, anti-inflammatory, and antitumor abilities but characterized by poor bioavailability and chemical instability, which drastically reduce its application in the treatment of chronic diseases such as osteoarthritis. The aim of the present study is the design and evaluation of monooleine aqueous dispersion (MAD) as novel carriers for the topical administration of CUR. CUR-loaded MAD was formulated using two different emulsifier systems, namely poloxamer 407 (MAD-A) and sodium cholate-sodium caseinate (MAD-B). These vehicles were characterized, and their influence on in vitro percutaneous absorption of CUR was also evaluated. Furthermore, an oxygen radical absorbance capacity assay was used to determine their antioxidant activity, and a Western blot analysis was performed to evaluate the inhibitory effect of the formulations on inducible nitric oxide synthase and cyclooxygenase 2 expressions. From the obtained results, CUR encapsulation efficiency was higher than 98% for MAD-A and 82% for MAD-B. Shelf-life studies showed that MAD-A maintains CUR stability better than MAD-B, and both vehicles demonstrated, in vitro, control of drug diffusion through the skin. Finally, MAD-A and MAD-B were able to extend the antioxidant/anti-inflammatory effects of CUR, also confirming the protective effect toward CUR chemical stability.


Asunto(s)
Antiinflamatorios no Esteroideos/administración & dosificación , Antioxidantes/administración & dosificación , Curcumina/administración & dosificación , Portadores de Fármacos/química , Glicéridos/química , Piel/metabolismo , Administración Tópica , Adulto , Antiinflamatorios no Esteroideos/farmacocinética , Antiinflamatorios no Esteroideos/farmacología , Antioxidantes/farmacocinética , Antioxidantes/farmacología , Caseínas/química , Curcumina/farmacocinética , Curcumina/farmacología , Emulsionantes/química , Humanos , Poloxámero/química , Absorción Cutánea , Colato de Sodio/química , Agua/química
18.
Med Chem ; 9(1): 84-90, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22762165

RESUMEN

5-Arylidene-2-oxo-4-thiazolidinones and 2-phenylimino analogues were evaluated for their antidegenerative activity on human chondrocyte cultures stimulated by IL-1ß and for their inhibitory capability against matrix metalloproteinase- 13. Our results indicated that 5-arylidene-4-thiazolidinone derivatives 1-9 exhibit antidegenerative activity and could block multiple cartilage destruction during the osteoarthritic process. Out of the selected compounds, (5-arylidene- 2,4-dioxothiazolidin-3-yl)acetic acids 7-9 showed significant effectiveness in reducing NO release and restoring normal levels of GAGs in chondrocytes treated with IL-1ß. Moreover, benzoic acids 1, 5 and 6 proved to be effective MMP-13 inhibitors and were able to restore normal levels of GAGs.


Asunto(s)
Condrocitos/efectos de los fármacos , Inhibidores de la Metaloproteinasa de la Matriz/química , Inhibidores de la Metaloproteinasa de la Matriz/farmacología , Tiazolidinedionas/química , Tiazolidinedionas/farmacología , Benzoatos/química , Benzoatos/farmacología , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Activación Enzimática/efectos de los fármacos , Humanos , Concentración 50 Inhibidora , Metaloproteinasa 13 de la Matriz/metabolismo , Estructura Molecular
19.
Life Sci ; 90(25-26): 968-74, 2012 Jun 27.
Artículo en Inglés | MEDLINE | ID: mdl-22634580

RESUMEN

AIMS: The present work evaluated the anti-inflammatory/antioxidant activity of a well characterized extract from Citrus bergamia Risso and Poiteau (CBE), containing neoeriocitrin, naringin, neohesperidin and other flavonoids, on human NCTC 2544 keratinocytes treated with interferon-gamma (IFN-γ) and histamine (H). MAIN METHODS: High performance liquid chromatography (HPLC) coupled with diode array detectors was used to characterize and quantify phenolic compounds in CBE. Anti-inflammatory/antioxidant ability on keratinocytes was determined through evaluation of inter-cellular adhesion molecule-1 (ICAM-1) and inducible nitric oxide synthase (iNOS) expression by Western blot, production of nitric oxide (NO) with Griess reagent and concentration of reactive oxygen species (ROS) by fluorescent quantitative analysis with 2',7'-dichlorfluorescein-diacetate (DCFH-DA). Cell viability was assessed using 3-(4,5-dimethyl-2 thiazoyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. Antioxidant activity was also measured by oxygen radical absorbance capacity (ORAC) assay. Glycosaminoglycans (GAGs) were quantified using 1.9-dimethyl methylene blue (DMB). KEY FINDINGS: CBE exhibited high antioxidant activity confirmed by elevated ORAC values related to high capacity in oxygen radical scavenging. The assays on keratinocytes demonstrated that CBE does not inhibit cell proliferation and is shown to significantly reduce dose-dependently ICAM-1, iNOS, NO, ROS and GAG production in cells exposed to IFN-γ and H. SIGNIFICANCE: Our study demonstrates that the pools of compounds of an extract from C. bergamia efficiently block the proinflammatory actions induced by IFN-γ and H on human keratinocytes. CBE may be used for topic employment in some inflammatory diseases of the skin and to represent an important opportunity for the essential oil processing industries.


Asunto(s)
Citrus/fisiología , Citoprotección/efectos de los fármacos , Histamina/toxicidad , Interferón gamma/toxicidad , Queratinocitos/efectos de los fármacos , Extractos Vegetales/farmacología , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Células Cultivadas , Citoprotección/fisiología , Humanos , Inflamación/inducido químicamente , Inflamación/metabolismo , Inflamación/prevención & control , Interferón gamma/efectos de los fármacos , Queratinocitos/metabolismo , Queratinocitos/patología , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...